Univercells: 'Micro-facilities' to slash the cost of vaccine manufacture
High-density single-use bioreactors, small facilities and continuous manufacturing will cut the cost of manufacturing polio vaccines down to $0.15 per dose, says Univercells.
Archives for October 20, 2017
Gilead ramping up CAR T clinics after US FDA Yescarta approval
Gilead says it is looking to make as many as 90 academic centres available to administer CAR-T Yescarta (axicabtagene ciloleucel) following its approval in the US.